TITLE

Plasma ghrelin levels in males with idiopathic hypogonadotropic hypogonadism

AUTHOR(S)
Cevdet Duran; Arif Yonem; Ihsan Ustun; Omer Ozcan; Osman Ipcioglu; Cihat Basekim
PUB. DATE
December 2008
SOURCE
Endocrine (1355008X);Dec2008, Vol. 34 Issue 1-3, p81
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Abstract  It has recently been shown that ghrelin is a pleitropic modulator with effects on diverse biological functions, such as energy homeostasis and reproduction. In this study, ghrelin levels and its relationship between metabolic and biochemical parameters were investigated in male subjects with idiopathic hypogonadotropic hypogonadism (IHH). Patients in the study were composed of 33 men with IHH, and controls were composed of 36 healthy age-matched men. The patients’ group had significantly higher waist/hip ratio (WHR), and lower testis volume, luteinizing hormone (LH), follicle stimuling hormone (FSH) and total testosterone (TT) levels when compared with controls. Plasma total ghrelin levels were significantly lower in patients than in controls (96.4 ± 29.1 ng/ml vs. 146.1 ± 28.9 ng/ml, P 
ACCESSION #
36232725

 

Related Articles

  • Crandall's syndrome. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p201 

    An encyclopedia entry for "Crandall's syndrome" is presented. It refers to a rare congenital disorder which runs in families. It is characterized by twisted, brittle hairs, sensorineural deafness and hypogonadism or the underdevelopment of the ovaries or testes. It is associated with...

  • A successful conception by a shift from human menopausal gonadotropin therapy to therapy with recombinant human follicular-stimulating hormone for the treatment of male hypogonadotropic hypogonadism. Koyama, Kohei; Masuda, Hiroshi; Inamoto, Teruo; Segawa, Naoki; Azuma, Haruhito; Katsuoka, Yoji // Reproductive Medicine & Biology;Mar2010, Vol. 9 Issue 1, p57 

    Stimulatory therapy with gonadotropins effectively induces spermatogenesis and increases the chances of successful reproduction. However, the optimal treatment modality and schedule, and required duration of treatment have not been determined. A 27-year-old man presented with erectile and...

  • The role of CD4+ CD25+ immunoregulatory T cells in the induction of autoimmune gastritis. Laurie, Karen L; Van Driel, Ian R; Gleeson, Paul A // Immunology & Cell Biology;Dec2002, Vol. 80 Issue 6, p567 

    Summary A number of experimental models of organ-specific autoimmunity involve a period of peripheral lymphopenia prior to disease onset. There is now considerable evidence that the development of autoimmune disease in these models is due to the absence of CD4+ CD25+ regulatory T cells. However,...

  • Continuing Medical Education Questions: February 2011. DeVault, Kenneth R.; Khanna, Reena; Win, Lay Lay // American Journal of Gastroenterology;Feb2011, Vol. 106 Issue 2, p224 

    A quiz concerning on biological therapy for pregnant and pediatric patients with inflammatory bowel diseases.

  • Biologic response modifiers. Dunkin, Mary Anne // Arthritis Today;Jul/Aug99, Vol. 13 Issue 4, p36 

    Provides information on biologic response modifiers (BRM). Purpose of BRM; Biologic agent approved to treat Crohn's disease.

  • Long-Term Administration of Gonadotropin-Releasing Hormone in Men with Idiopathic Hypogonadotropic Hypogonadism. Spratt, Daniel I.; Finkelstein, Joel S.; O'Dea, Louis St. L.; Badger, Thomas M.; Rao, Narasimha; Campbell, Jam D.; Crowley, William F. // Annals of Internal Medicine;Dec86, Vol. 105 Issue 6, p848 

    Studies effect of long-term administration of gonadotropin-releasing hormone in men with idiopathic hypogonadotropic hypognadism. Deficiency in gonadotropin-releasing hormone secretion in men with idiopathic hypogonadotropic hypogonadism; Methodology of the study; Discussion on the result of...

  • Mutations along the hypothalamic--pituitary--gonadal axis affecting male reproduction. Huhtaniemi, Ilpo; Alevizaki, Maria // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Dec2007, Vol. 15 Issue 6, p622 

    Disorders in male reproductive function are caused by mutations of key genes at all levels of the hypothalamic--pituitary--testicular axis. They may affect the ontogeny and function of the hypothalamic centres governing gonadotrophin synthesis and secretion, the development of the anterior...

  • Phenotypic spectrum and hormonal profile in hypogonadotropic hypogonadism. Păun, D.; Gherlan, I.; Popescu, I.; Procopiuc, C.; Dumitrescu, C.; Brehar, A.; Dinu, D.; Neamtu, C.; Poiana, C.; Dumitrache, C. // Journal of Medicine & Life;Jan-Mar2014, Vol. 7 Issue 1, p42 

    Background: Hypogonadotropic hypogonadism (HH) is characterized by inappropriately low serum concentration of LH (luteinizing hormone) and FSH (follicle-stimulated hormone) in the setting of hypogonadism. A number of pathologic processes cause Hypogonadotropic hypogonadism but it can also occur...

  • Patients’ preferences for adjuvant endocrine therapy in early breast cancer: what makes it worthwhile? Duric, V. M.; Fallowfield, L. J.; Saunders, C.; Houghton, J.; Coates, A. S.; Stockler, M. R. // British Journal of Cancer;12/12/2005, Vol. 93 Issue 12, p1319 

    Adjuvant endocrine therapy improves recurrence and survival rates, but has side effects and is inconvenient. The aim of this study was to determine the preferences of premenopausal women who had adjuvant endocrine therapy in a randomised trial. In all, 85 (or eighty-five) women completed...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics